{"id":"https://openalex.org/W7223180897","doi":"https://doi.org/10.2147/dmso.s637243","title":"Pancreatic and Gallbladder Adverse Events Associated with Tirzepatide in Obesity Management: A Scoping Review","display_name":"Pancreatic and Gallbladder Adverse Events Associated with Tirzepatide in Obesity Management: A Scoping Review","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223180897","doi":"https://doi.org/10.2147/dmso.s637243","pmid":"https://pubmed.ncbi.nlm.nih.gov/42948670","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13712152"},"language":"en","primary_location":{"id":"doi:10.2147/dmso.s637243","doi":"https://doi.org/10.2147/dmso.s637243","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s637243","pdf_url":"https://www.ema.europa.eu/en/documents/product-information/mounjaro-epar-product-information_en.pdf","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.ema.europa.eu/en/documents/product-information/mounjaro-epar-product-information_en.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5139796812","display_name":"Tetiana Kutsyba","orcid":"https://orcid.org/0009-0001-9171-3633","observed_orcids":["https://orcid.org/0009-0001-9171-3633"]},"institutions":[{"id":"https://openalex.org/I39555362","display_name":"University of Warwick","ror":"https://ror.org/01a77tt86","country_code":"GB","type":"education","lineage":["https://openalex.org/I39555362"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Tetiana Kutsyba","raw_affiliation_strings":["Pharmacovigilance Department, Macleods Pharmaceuticals Limited, Kyiv, Ukraine","The University of Warwick, Coventry, UK"],"raw_orcid":"https://orcid.org/0009-0001-9171-3633","affiliations":[{"raw_affiliation_string":"Pharmacovigilance Department, Macleods Pharmaceuticals Limited, Kyiv, Ukraine","institution_ids":[]},{"raw_affiliation_string":"The University of Warwick, Coventry, UK","institution_ids":["https://openalex.org/I39555362"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111485401","display_name":"Sonika Raj","orcid":"https://orcid.org/0000-0002-1843-0389","observed_orcids":["https://orcid.org/0000-0002-1843-0389"]},"institutions":[{"id":"https://openalex.org/I230495080","display_name":"University of Limerick","ror":"https://ror.org/00a0n9e72","country_code":"IE","type":"education","lineage":["https://openalex.org/I230495080"]},{"id":"https://openalex.org/I39555362","display_name":"University of Warwick","ror":"https://ror.org/01a77tt86","country_code":"GB","type":"education","lineage":["https://openalex.org/I39555362"]},{"id":"https://openalex.org/I45294948","display_name":"Post Graduate Institute of Medical Education and Research","ror":"https://ror.org/009nfym65","country_code":"IN","type":"education","lineage":["https://openalex.org/I45294948"]}],"countries":["GB","IE","IN"],"is_corresponding":false,"raw_author_name":"Sonika Raj","raw_affiliation_strings":["Post Graduate Institute of Medical Education and Research, Chandigarh, India","The University of Warwick, Coventry, UK","University of Limerick, Limerick, Ireland"],"raw_orcid":"https://orcid.org/0000-0002-1843-0389","affiliations":[{"raw_affiliation_string":"Post Graduate Institute of Medical Education and Research, Chandigarh, India","institution_ids":["https://openalex.org/I45294948"]},{"raw_affiliation_string":"The University of Warwick, Coventry, UK","institution_ids":["https://openalex.org/I39555362"]},{"raw_affiliation_string":"University of Limerick, Limerick, Ireland","institution_ids":["https://openalex.org/I230495080"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5159242130","display_name":"Malisha van der Berg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39555362","display_name":"University of Warwick","ror":"https://ror.org/01a77tt86","country_code":"GB","type":"education","lineage":["https://openalex.org/I39555362"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Malisha van der Berg","raw_affiliation_strings":["The University of Warwick, Coventry, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Warwick, Coventry, UK","institution_ids":["https://openalex.org/I39555362"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5139796812"],"corresponding_institution_ids":["https://openalex.org/I39555362"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.5552,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"Volume 19","issue":null,"first_page":"1","last_page":"38"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.013899999670684338,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.7620000243186951},{"id":"https://openalex.org/keywords/pancreatitis","display_name":"pancreatitis","score":0.9330000281333923},{"id":"https://openalex.org/keywords/gallstones","display_name":"gallstones","score":0.9909999966621399},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6119999885559082},{"id":"https://openalex.org/keywords/gip-glp-1-receptor-agonist","display_name":"GIP/GLP-1 receptor agonist","score":0.9070000052452087},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.46700000762939453},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8840000033378601},{"id":"https://openalex.org/keywords/adverse-event-reporting","display_name":"adverse event reporting","score":0.6480000019073486},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.3569999933242798},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.4580000042915344},{"id":"https://openalex.org/keywords/fda-adverse-event-reporting-system","display_name":"FDA Adverse Event Reporting System","score":0.6579999923706055},{"id":"https://openalex.org/keywords/eudravigilance","display_name":"EudraVigilance","score":0.9679999947547913},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8428000211715698},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.657800018787384},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.5378999710083008},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5361999869346619},{"id":"https://openalex.org/C2777148285","wikidata":"https://www.wikidata.org/wiki/Q64386","display_name":"Gallbladder","level":2,"score":0.4878999888896942},{"id":"https://openalex.org/C2776493420","wikidata":"https://www.wikidata.org/wiki/Q5518905","display_name":"Gallbladder disease","level":3,"score":0.42480000853538513},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33559998869895935},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.31150001287460327},{"id":"https://openalex.org/C2776641081","wikidata":"https://www.wikidata.org/wiki/Q638774","display_name":"Cholecystectomy","level":2,"score":0.27900001406669617},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2784999907016754},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.27000001072883606},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2567000091075897},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.25589999556541443}],"mesh":[],"locations_count":7,"locations":[{"id":"doi:10.2147/dmso.s637243","doi":"https://doi.org/10.2147/dmso.s637243","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s637243","pdf_url":"https://www.ema.europa.eu/en/documents/product-information/mounjaro-epar-product-information_en.pdf","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13712152","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13712152/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13712152/pdf/DMSO-19-637243.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Metab Syndr Obes","raw_type":"Text"},{"id":"pmid:42948670","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42948670","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, metabolic syndrome and obesity : targets and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:1b8c0ba7f9ef4d4898aac88ef829741e","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/1b8c0ba7f9ef4d4898aac88ef829741e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity, Vol Volume 19, Iss Issue 1, Pp 1-38 (2026)","raw_type":"article"},{"id":"pmh:oai:researchrepository.ul.ie:10344/32359","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/10344/32359","pdf_url":null,"source":{"id":"https://openalex.org/S7407055152","display_name":"University of Limerick Research Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:dovepress.com/121252","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/pancreatic-and-gallbladder-adverse-events-associated-with-tirzepatide--peer-reviewed-fulltext-article-DMSO","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Review"},{"id":"doi:10.34961/19954","doi":"https://doi.org/10.34961/19954","is_oa":true,"landing_page_url":"https://doi.org/10.34961/19954","pdf_url":null,"source":{"id":"https://openalex.org/S4306401530","display_name":"University of Limerick Institutional Repository (University of Limerick)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I230495080","host_organization_name":"University of Limerick","host_organization_lineage":["https://openalex.org/I230495080"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.2147/dmso.s637243","doi":"https://doi.org/10.2147/dmso.s637243","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s637243","pdf_url":"https://www.ema.europa.eu/en/documents/product-information/mounjaro-epar-product-information_en.pdf","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320320279","display_name":"University of Warwick","ror":"https://ror.org/01a77tt86"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223180897.pdf","grobid_xml":"https://content.openalex.org/works/W7223180897.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7081187001","https://openalex.org/W7166873210","https://openalex.org/W4409239595","https://openalex.org/W4410921418","https://openalex.org/W4403720889","https://openalex.org/W7084930856","https://openalex.org/W7153266178","https://openalex.org/W4416263460","https://openalex.org/W4404596050","https://openalex.org/W4416031226"],"abstract_inverted_index":{"Background:":[0],"Obesity":[1],"is":[2],"a":[3,23,37,480],"chronic":[4],"and":[5,12,19,50,57,79,93,103,119,127,140,158,215,220,226,250,299,324,372,388,411,426,441,447,453,465,494,508],"relapsing":[6],"condition":[7],"that":[8],"affects":[9],"all":[10,370],"demographics":[11],"results":[13],"in":[14,71,190,256,261,285,314,354,487],"comorbidities,":[15],"rising":[16],"healthcare":[17],"costs,":[18],"social":[20],"challenges.":[21],"Tirzepatide,":[22],"novel":[24],"dual":[25],"glucose-dependent":[26],"insulinotropic":[27],"polypeptide":[28],"(GIP)/glucagon-like":[29],"peptide-1":[30],"(GLP-1)":[31],"receptor":[32],"agonist,":[33],"has":[34],"emerged":[35],"as":[36,171],"promising":[38],"therapy":[39],"offering":[40],"significant":[41],"weight":[42],"reduction.":[43],"However,":[44],"uncertainty":[45],"remains":[46],"regarding":[47],"its":[48],"pancreatic":[49,186],"gallbladder":[51,188,221,251,412,454],"safety":[52,68,121,519],"profile":[53,520],"across":[54,84,134,240,264,288,449,458,503],"different":[55],"populations":[56],"evidence":[58,65,150,504],"sources.":[59,505],"Aim:":[60],"To":[61],"systematically":[62,224],"map":[63],"existing":[64],"on":[66,77,163],"the":[67,98,137,141,164,191,233,355,359,378,429,495,517],"of":[69,101,193,274,279,297,301,306,319,335,369,374,473,483,497,521],"tirzepatide":[70,194],"obesity":[72],"management,":[73],"with":[74,107,148,198,267,291,317],"an":[75,172,332],"emphasis":[76],"pancreatic-":[78],"gallbladder-related":[80,392],"adverse":[81],"events":[82,337,350],"(AEs)":[83],"randomized":[85],"controlled":[86],"trials":[87],"(RCTs),":[88],"observational":[89,117,206,309,461],"studies,":[90,118,207,310,316,462],"case":[91,209,396,463],"reports,":[92,210,464],"pharmacovigilance":[94,160,213,361,466,477],"evidence.":[95],"Methods:":[96],"Following":[97],"methodological":[99],"framework":[100],"Arksey":[102],"O'Malley":[104],"(2005),":[105],"expanded":[106],"Joanna":[108],"Briggs":[109],"Institute":[110],"guidance,":[111],"this":[112],"scoping":[113],"review":[114,201],"included":[115,202],"RCTs,":[116,204,266,290],"post-marketing":[120],"reports":[122,386,393,397],"identified":[123,151],"between":[124],"December":[125],"2019":[126],"September":[128],"2025.":[129],"The":[130,200],"searches":[131],"were":[132,181,223,237,253,444,456],"conducted":[133],"PubMed,":[135],"EMBASE,":[136],"Cochrane":[138],"Library,":[139],"FDA":[142],"Adverse":[143],"Event":[144],"Reporting":[145],"System":[146],"(FAERS),":[147],"additional":[149,173],"through":[152],"gray":[153],"literature,":[154],"targeted":[155],"journal":[156],"searches,":[157],"published":[159],"studies":[161],"based":[162],"EudraVigilance":[165,212,360],"database.":[166],"ClinicalTrials.gov":[167],"was":[168,259,283,312,346],"subsequently":[169],"searched":[170],"source":[174],"to":[175,276,303,514],"identify":[176],"relevant":[177],"clinical":[178,459],"trials.":[179],"Studies":[180],"eligible":[182],"if":[183],"they":[184],"examined":[185],"or":[187],"AEs":[189,222,252,367,371,455],"context":[192],"exposure":[195,498],"among":[196,341,434],"individuals":[197],"obesity.":[199],"11":[203,262,289],"5":[205],"4":[208],"1":[211,300],"analysis,":[214,362],"575":[216],"FAERS":[217,379],"reports.":[218],"Pancreatic":[219,249,452],"extracted":[225],"coded":[227],"using":[228],"MedDRA":[229],"version":[230],"28.1,":[231],"following":[232],"predetermined":[234],"hierarchy.":[235],"Findings":[236],"mapped":[238],"descriptively":[239],"data":[241],"sources":[242],"without":[243],"formal":[244],"comparative":[245],"statistical":[246],"testing.":[247],"Results:":[248],"reported":[254,260,284,313,331,347,366,416,435,446,457,470,484],"infrequently":[255],"RCTs.":[257],"Pancreatitis":[258],"participants":[263,287,427],"five":[265],"study-specific":[268],"frequencies":[269,292,472],"ranging":[270,293],"from":[271,294,428],"0.2%":[272],"(3":[273],"1,896)":[275],"3.7%":[277,304],"(1":[278,296,305],"27),":[280],"while":[281,344],"cholelithiasis":[282,345,389],"73":[286],"0.3%":[295],"335":[298],"364)":[302],"27).":[307],"Among":[308],"pancreatitis":[311,363,381,406],"three":[315],"proportions":[318],"0.6%":[320],"(63/10,002),":[321],"0.9%":[322],"(1/110),":[323],"2.1%":[325],"(5,882/280,094).":[326],"One":[327],"retrospective":[328],"cohort":[329],"study":[330,488],"incidence":[333],"rate":[334],"3.84":[336],"per":[338,351],"1,000":[339,352],"person-years":[340,353],"9,193":[342],"participants,":[343,419,421],"at":[348],"11.89":[349],"same":[356],"cohort.":[357],"In":[358,377],"represented":[364],"363":[365],"(6.3%":[368],"19.4%":[373],"gastrointestinal":[375],"AEs).":[376],"database,":[380],"accounted":[382],"for":[383,390],"155/288":[384],"pancreatic-related":[385],"[53.8%]":[387],"143/249":[391],"[57.4%].":[394],"Four":[395],"described":[398],"six":[399],"distinct":[400],"AEs:":[401],"edematous":[402],"pancreatitis,":[403,405],"acute":[404],"necrotizing,":[407],"acalculous":[408],"cholecystitis,":[409],"gallstones,":[410],"wall":[413],"thickening,":[414],"each":[415],"once.":[417],"Female":[418],"White":[420],"adults":[422],"aged":[423],"18-64":[424],"years,":[425],"United":[430],"States":[431],"(US)":[432],"predominated":[433],"demographic":[436,439],"characteristics;":[437],"however,":[438],"characteristics":[440],"comorbidity":[442,490],"profiles":[443],"inconsistently":[445],"varied":[448],"studies.":[450],"Conclusion:":[451],"trials,":[460],"databases.":[467],"RCTs":[468],"generally":[469],"low":[471],"pancreatobiliary":[474,518],"AEs,":[475],"whereas":[476],"databases":[478],"captured":[479],"broader":[481],"spectrum":[482],"events.":[485],"Variability":[486],"populations,":[489],"profiles,":[491],"reporting":[492,511],"methods,":[493],"absence":[496],"denominators":[499],"limited":[500],"direct":[501],"comparison":[502],"Vigilant":[506],"monitoring":[507],"standardized":[509],"AE":[510],"are":[512],"needed":[513],"further":[515],"characterize":[516],"tirzepatide.":[522]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-22T00:00:00"}